Translational Health Research Institute (THRI), Western Sydney University, Locked Bag 1797, Penrith, New South Wales, 2751, Australia.
Rozetta Institute (Formerly Capital Markets Cooperative Research Centre), Level 4/55, Harrington Street, The Rocks, Sydney, New South Wales, 2000, Australia.
BMC Fam Pract. 2020 Aug 8;21(1):158. doi: 10.1186/s12875-020-01230-w.
Studies report that increased levels of patient activation is associated with increased engagement with the health care system, better adherence to treatment protocols, and improved health outcomes. This study aims to evaluate the outcomes of a 12-month Patient-Centred Medical Home (PCMH) model called 'WellNet' on the activation levels of patients with one or more chronic diseases in general practices across Northern Sydney, Australia.
A total of 636 patients aged 40 years and above with one or more chronic conditions consented to participate in the WellNet program which was delivered across six general practices in Northern Sydney, Australia. The WellNet intervention includes team-based care with general physicians and trained chronic disease management care coordinators collaborating with patients in designing a patient-tailored care plan with improved self-management support and care navigation according to the level of risk and health care needs. The level of patient activation was measured using the validated PAM 13-item scale at baseline and follow-up. A before and after case-series design was employed to determine the adjusted mean differences between baseline and 12-months using repeated measures analysis of covariance (ANCOVA). Additionally, the backward stepwise multivariable regression models were employed to identify significant predictors of activation at follow-up.
Of the 626 patients, 420 reported their PAM scores at follow-up. The mean (SD) baseline PAM score was 57.9 (13.0). The adjusted model showed significant mean difference in PAM scores by increase of 6.5 (95% CI 5.0-8.1; p-value< 0.001) after controlling for baseline covariates. The multivariable regression models showed that older age (B = - 0.14; 95% CI -0.28, - 0.01) and private insurance (uninsured patients) (B = - 3.41; 95% CI -6.50, - 0.32) were significantly associated with lower PAM scores at 12 months whereas higher baseline PAM score (B = 0.48; 95% CI 0.37, 0.59) was significantly associated with higher follow-up PAM score.
The WellNet study is the first of its kind in Australia to report on changes in the patient activation levels among patients with one or more chronic diseases. PCMH has the potential to improve patient activation and engagement which can lead to long-term health benefits and sustained self-management behaviours.
研究报告称,患者的激活水平升高与更多地参与医疗保健系统、更好地遵循治疗方案以及改善健康结果有关。本研究旨在评估澳大利亚北悉尼六家全科诊所开展的为期 12 个月的以患者为中心的医疗之家(PCMH)模式“ WellNet ”对患有一种或多种慢性病的患者的激活水平的影响。
共有 636 名年龄在 40 岁及以上且患有一种或多种慢性病的患者同意参加 WellNet 计划,该计划在澳大利亚北悉尼的六家全科诊所开展。 WellNet 干预措施包括团队式护理,全科医生和经过培训的慢性病管理护理协调员与患者合作,根据风险和医疗保健需求,为患者量身定制护理计划,提供更好的自我管理支持和护理导航。使用经过验证的 PAM 13 项量表在基线和随访时测量患者的激活水平。采用前后病例系列设计,使用重复测量协方差分析(ANCOVA)确定基线和 12 个月时的调整后平均差异。此外,采用向后逐步多变量回归模型确定随访时激活的显著预测因素。
在 626 名患者中,有 420 名报告了他们的 PAM 评分在随访时的情况。平均(SD)基线 PAM 得分为 57.9(13.0)。调整后的模型显示,在控制基线协变量后,PAM 评分的平均差异显著增加 6.5(95%CI 5.0-8.1;p<0.001)。多变量回归模型显示,年龄较大(B=-0.14;95%CI-0.28,-0.01)和私人保险(无保险患者)(B=-3.41;95%CI-6.50,-0.32)与 12 个月时的较低 PAM 评分显著相关,而较高的基线 PAM 评分(B=0.48;95%CI 0.37,0.59)与较高的随访 PAM 评分显著相关。
WellNet 研究是澳大利亚首例报告患有一种或多种慢性病的患者的患者激活水平变化的研究。PCMH 有可能提高患者的激活和参与度,从而带来长期的健康益处和持续的自我管理行为。